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Background: Cesarean myomectomy (CM) is, for many gynecologists, a discussed surgical procedure character-
ized by fibroid’s removal during cesarean section (CS) followed by possible complications. For a long time, it has 
been common and shared thinking that myoma should not be surgically treated in pregnant women at the time 
of birth through CS in order to avoid complications for the patient. Nowadays, many studies reconsidered the 
feasibility of CM. The aim of this investigation is to summarize the scientific evidences on this procedure, high-
lighting when and how it can be performed safely. 
Methods: This review has realized basing on evidences reported in scientific database, as PubMed, Scopus, 
Cochrane Library, Medline and EMBASE databases, found using key words of reference to the main topic, the 
cesarean myomectomy. All the observational studies and meta-analysis published in the current century has been 
considered and results were critically evaluated by the authors, experts on CM. 
Results: According to the findings reported, the CM could be a valid and feasible treatment option for patients, 
especially when there are specific conditions which are associated with a lower risk of complications, as peri-
operative blood loss and risk of hysterectomy. Authors’ experience and judgment agree with the evidences about 
the importance of the surgeons’ skill and experience, both to make safer the surgical procedure and to have intra-
operative and post-surgical outcomes.  
Conclusion: The applied surgical technique and the informative counselling and/or informed consent, still need 
standardization for a safer CM, both for the patients and for the operator, at the same time. 
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1. Introduction 
 
In the last decades epidemiological data have 
reported a growing rise of the average pregnant 
age: This phenomenon hits mostly industrial-
ized countries, where the percentage of women 
giving birth to a child in their 40’s has more 
than doubled to date (Bellieni 2016). Postpon-
ing pregnancy and delayed childbearing have 
brought to light problems of management of 
coexisting organic diseases. The incidence of 
such pathologies is directly linked to the age, 
therefore obstetricians have had to face new 
clinical questions on topics less frequent and 
less investigated in the past. This lead to reeval-
uate and subvert ancient axioms and precon-
ceptions, bringing out an innovative obstruct 
point of view: the caesarean myomectomy. This 
surgical procedure is currently discussed for the 
risk of complications during and after surgery. 
Myomas or leiomyoma, also known as uterine 
fibroids, are the most common benign lesions 
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in women, prevalently consisting of monoclo-
nal smooth muscle cell. Fibroids’ presence dur-
ing pregnancy is often associated with a high 
risk of cesarean section, as well as peripartum 
hemorrhage (Laughlin, Schroeder, and Baird 
2010; Sparić 2014; Klatsky et al. 2008). The 
prevalence of myomas ranges between 20% and 
25%, while their incidence can be up to 70% in 
women of reproductive age (‘Myomas and Re-
productive Function’ 2004; ‘Myomas and Re-
productive Function’ 2006).   
 
2. Epidemiology of fibroids’ in pregnancy 
 
According to increase of maternal age men-
tioned above, the prevalence of fibroids during 
pregnancy has been increasing too during these 
years, shifting from 0.1%-3.9%, as reported in 
the initial reports, up to 10.7% in the most re-
cent evidences (Cooper and Okolo 2005; Ex-
acoustòs and Rosati 1993; Hartmann et al. 
2009). Considering that these data are based on 
ultrasound assessment during pregnancy, it 
could be considered underestimated, because 
only 4% of myomas in pregnant women are di-
agnosed by ultrasound (Svigos, Robinson, and 
Vigneswaran 2006) and so many of them are 
detected mostly during cesarean delivery (Ex-
acoustòs and Rosati 1993; Hartmann et al. 
2009). This is also the reason why the choice of 
removing of myomas during cesarean delivery 
is not always an elective and premeditated one, 
but often it is made impromptu at operating ta-
ble. Therefore, it is important to have good sci-
entific evidences that can correctly guide the 
management of these lesions during pregnancy 
and mostly at the time of childbirth in order to 
guarantee the best outcomes for the patient. 
Nevertheless, cesarean myomectomy seems to 
be not yet sufficiently studied, this surgical pro-
cedure has its roots in the past. 
 
3. History of cesarean myomectomy 
 
It was reported in literature for the first time at 
the beginning of the twentieth century, when 
Bonney successfully removed up to six fibroids 
without any complications for the patient, who 
had three subsequent uncomplicated vaginal de-
liveries (Jauniaux and Khan 2014). Several other 
attempts followed in subsequent years, many of 
which were uneventful, but at the same time 
emerges a series of complications which appar-
ently have a higher incidence in this type of 
procedure rather than cesarean section only 
(Lolis, Zikopoulos, and Paraskevaidis 1994). 
Finally, cesarean myomectomy was strongly 
discouraged also by worthy textbooks (Park and 
Kim 2009; Sparic et al. 2014), as Te Linde’s too 
(‘Te Linde’s Operative Gynecology; Mattingly 
RF 1977). 
Despite of this, the choice to avoid fibroid re-
moval in pregnant women at the time of child-
birth is not altogether a safer choice (Davis et 
al. 1990; Kwawukume 2002). In fact several 
studies are trying to attest the feasibility of ce-
sarean myomectomy, because, as well as sup-
ported by many obstetricians, performing this 
apparently hazardous procedure through a safer 
way allows, on the other hand, in a single surgi-
cal time, to reduce other risks related to myoma 
in pregnancy and delivery (Klatsky et al. 2008; 
Park and Kim 2009), like: 
-fertility impairment, miscarriage, placental in-
sertion anomalies, alteration of fetal growth, fe-
tal malpresentation, preterm birth and dystocia 
for subsequent pregnancy; 
-peri-partum hemorrhage at the time of delivery 
with persistence of fibroid in situ; 
-uterine rupture during pregnancy, in case of 
previous myomectomy. 
Especially the latter represents two severe con-
ditions burdened by a high rate of morbidity 
and mortality. In cases of previous myomecto-
my, the onset of a uterine rupture at the site of 
the scar during pregnancy or in labor is an oc-
currence which happens 0.2%-3.7% in an un-
predictable way. According to some authors, 
uterine rupture is not always related to the 
length of interval between the fibroid removal 
and conception, as a matter of fact there is not 
an ideal interval which completely reset this risk 
(Gambacorti-Passerini et al. 2016). Moreover, 
the presence of one or more myomas, especially 
when they are large and/or intramural located, 
can hinder myometrium contractility mostly 
immediately after delivery and afterbirth, facili-
tating the onset of a life-threatening condition, 
like postpartum hemorrhage (Davis et al. 1990; 
Park and Kim 2009). 
 
4. Fibroids’ management during delivery 
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Fibroid removal during cesarean delivery could 
be an option to promote the physiological he-
mostatic effect of uterine contractions, making 
postpartum safer as far as possible, on the basis 
of modifiable etiological factors. Paradoxically, 
the most feared complication mentioned for ce-
sarean myomectomy is just massive blood loss, 
which can happen intra and post-partum and 
which can be sometimes the reason for a hys-
terectomy. What lead many obstetricians to opt 
for fibroids removal during cesarean delivery, 
rather than leaving myomas in place, is that the 
recent experience on this surgical procedure has 
even more shown the possibility to reduce the 
hemorrhage risk, after taking specific precau-
tions and techniques (Qidwai, Caughey, and 
Jacoby 2006; Cunningham et al. 2001).  Fur-
thermore, a really relevant benefit of cesarean 
myomectomy rather than myomectomy follow-
ing pregnancy or the other way around is that a 
single surgical time significantly reduce costs 
and anesthetic complications, resulting more 
feasible in terms of cost and benefits (Awoleke 
2013; Lolis, Zikopoulos, and Paraskevaidis 
1994)). 
According to recent studies performing a my-
omectomy during a cesarean section instead of 
on non-pregnant woman should be more suita-
ble and advantageous for the surgeon as well as 
for the patient herself for several reason (Sparić 
et al. 2019; Hatırnaz et al. 2020; Tinelli et al. 
2014). First of all, considering both that, con-
trary to what was thought in the past, myoma’s 
dimension does not significantly varies during 
pregnancy (Muram, Gillieson, and Walters 
1980). The volume of the uterine mass growths 
proportionally to amenorrhea (Shynlova et al. 
2009) and fibroid is however relatively smaller 
than pregnant uterus. Therefore, the uterine in-
cision needed to remove fibroid will be respec-
tively always smaller during cesarean myomec-
tomy rather than on a non-pregnant uterus, fa-
voring wound healing with a smaller scar and so 
a lower risk of subsequent dehiscence or uter-
ine rupture (Sparić et al. 2017). Moreover, dur-
ing pregnancy, the gradual hypertrophy and hy-
perplasia of uterine smooth muscle cells, which 
develops also around myoma, facilitate the dis-
tinction between the lesion and the muscular 
layer, being more visible the cleavage plane. 
The easier removal of myoma reflects also the 
possibility to apply easier specific technique of 
myomectomy associated with lower risk of 
blood loss, like intracapsular myoma removing 
(Tinelli et al. 2014). 
So that all this modification inevitably, contrary 
of what sustained in the past, can be considered 
the basis to reduce the risk of complications, 
making easier for the surgeon to use specific 
technique in order to limit the blood loss and 
other complications related to cesarean myo-
mectomy. 
 
5. Safety of cesarean myomectomy 
 
The studies reported in literature on cesarean 
myomectomy are not yet enough satisfactory by 
a statistical point of view in term of quantity 
and quality of the evidences in order to defini-
tively establish the safety and feasibility of the 
procedure. As a matter of fact, scientific data-
bases reported less than thirty observational 
studies on the subject in question and, to date, 
no randomized controlled trial. Moreover most 
of them are retrospective studies and in the cur-
rent century only six are the prospective studies 
mentioned in literature, which were respectively 
conducted by Kwawukume, first, in 2002 (40), 
Li et al in 2009 (41), Lin et al in 2010 (42), 
Tinelli et al in 2013 (43) and the two published 
in 2017 respectively by Valson et al (44) and by 
Rai and Mishra (45). No further and more re-
cent prospective studies on cesarean myomec-
tomy are reported in literature.  With the sole 
exception of the Li’s study, for which a total of 
1387 patients were enrolled, 1242 cases and 145 
controls, the other prospective studies are char-
acterized by a small sample, well below hun-
dreds (Kwawukume 2002; Li et al. 2009; Lin et 
al. 2010; Tinelli et al. 2014), mostly the two 
more recent ones (Rai and Mishra 2017; 
Valson, Nazer, and Mukerjee 2017). Retrospec-
tive studies on cesarean myomectomy, although 
more numerous, are almost burdened by the 
same limitation (Pergialiotis et al. 2017) and, for 
this reason, the latest study conducted by Zhao 
et al in 2019 stands out among them, having so 
far the biggest sample of patients, 2565 women 
all in all, whom 2344 underwent cesarean my-
omectomy and 221 cesarean delivery alone 
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(Zhao et al. 2019). The dimension of sample 
and the nature of the studies are the most 
strong limitations which allows to let many ob-
stetricians still doubt quality of the study re-
sults, although the common findings of all the 
them  seems to direct towards rather than 
against cesarean myomectomy (Zhao et al. 
2019; Pergialiotis et al. 2017; Guler et al. 2020; 
Nargis, Karim, and Loverine 2019; Sparić et al. 
2019, 2018; Senturk et al. 2017; Hatırnaz et al. 
2020; Kwawukume 2002; Li et al. 2009; Lin et 
al. 2010; Tinelli et al. 2014; Rai and Mishra 
2017; Valson, Nazer, and Mukerjee 2017). 
 
6. Complications of cesarean myomectomy 
 
Among the most feared intraoperative and/or 
postoperative complication related to cesarean 
myomectomy, the massive hemorrhage repre-
sents a common condition investigated by re-
searchers. In several studies, obstetrics tried to 
investigated the real incidence and relevance of 
intra and post-surgical hemorrage, referring to 
different variables as: absolute value of blood 
loss, point of hemoglobin lost, anemia, need of 
transfusion and number of units transfused, 
need of hysterectomy. Therefore, the heteroge-
neous meaning attributed to the concept of 
massive blood loss represented an interpreta-
tional limit in order to have a global view from 
available of literature. About that highly useful 
and interesting is the statistical meta-analysis 
conducted in 2017 by Pergiaolitis et al., who se-
lected all observational studies on cesarean my-
omectomy published until then, which amount-
ed to only nineteen, in order to highlight the 
most frequent and significant complications as-
sociated (Pergialiotis et al. 2017). They surpris-
ingly reported that, although the 2,301 patients 
undergoing cesarean myomectomy compared 
to the cesarean delivery group, 1,599 women, 
had been exposed to a longer intraoperative du-
ration and to a greater mean hemoglobin drop, 
this statistically relevant data did not necessarily 
translate into a greater and significant clinical 
risk for the patient.  In fact, the mean differ-
ence of hemoglobin drop reported between the 
two groups only amounted to 0.25 mg/dL 
(95% CI 0.06–0.45) and on the other hand the 
mean difference of duration of the operation 
was 13.87 minutes (95% CI 4.78–22.95). It 
could be considered a reasonable unreached of 
surgical time if compared with the possible 
benefits deriving from the procedure, without 
any significant impact on the rapidity of post-
operative patient recovery. Moreover, no dif-
ference on haemorrhage, transfusion rates, or 
postoperative fever was reported between the 
two groups and the prolonged hospitalization 
recorded in cesarean myomectomy group, 
though statistically significant, was minimum 
and scarcely relevant in clinical terms and for 
patient health all in all (Pergialiotis et al. 2017). 
This reconfirmed the safety and feasibility of 
the myomectomy during cesarean delivery al-
ready suggested by the findings of a previous 
meta-analysis conducted in 2013 by Song et al, 
who reported a longer surgical time and a 
greater hemoglobin drop, while not achieving 
statistical significance (Song et al. 2013). Two 
observational studies conducted in the same 
year of Pergiaolitis’ meta-analysis (Rai and 
Mishra 2017; Valson, Nazer, and Mukerjee 
2017) and further observational studies pub-
lished in the following years, all retrospective 
and none prospective as mentioned above, have 
remarked the relatively safety of the procedure, 
not reporting a significant increase of blood 
loss and massive haemorrhage as intra e post-
operative complication for caesarean myomec-
tomy. Mostly, not evidenced a considerable 
worsening of clinical outcomes for this set of 
patients  (Guler et al. 2020; Nargis, Karim, and 
Loverine 2019; Sparić et al. 2019, 2018; Senturk 
et al. 2017). As a matter of fact, a common 
finding is a very low rate of incidence of so-
called major complications, as blood transfu-
sion or hysterectomy, this latter almost null 
(Pergialiotis et al. 2017; Nargis, Karim, and 
Loverine 2019; Sparić et al. 2019, 2018; Senturk 
et al. 2017; Hatırnaz et al. 2020). For example 
Valson et al in their recent prospective study 
reported on a total of twelve women with fi-
broids underwent lower segment cesarean sec-
tion with myomectomy following delivery only 
three cases, who needed blood transfusion after 
surgery. Although the several patient-myoma 
and procedure variables investigated, the au-
thors did not find an exact reason to explain the 
onset of this complication (Valson, Nazer, and 
Mukerjee 2017). Instead Pergiaolitis et al, as 
mentioned above, on the basis of the analysed 
studies, detected an hemorrhage incidence, as a 
blood loss major than 1000mL, and rate of 
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blood transfusion as independent variables, 
which do not achieve a statistically significance 
p-value between the cesarean myomectomy 
group and the cesarean delivery group (Pergi-
aliotis et al. 2017). 
 
7. Blood loss during cesarean myomectomy: 
clinical strategy to contain hemoglobin drop 
 
Despite its clinical relevance, the greater hemo-
globin drop as in fact a constant findings in 
women underwent myomectomy removal after 
cesarean delivery, therefore a common trend, 
mostly in the recent studies, is to focus on pos-
sible strategies available during procedure in 
order to prevent and contain blood loss with 
the aim to test their real effectiveness. One of 
the most investigated is the pharmacological 
strategy, based on the employment of uteroton-
ics, administrated in different ways and in dif-
ferent moments of the surgical procedure, fa-
voring myometrium, especially the perilesional 
one, contraction in order to avoid atony and so 
massive bleeding. Already in 1999 Brown et al 
in his case-controlled study chose to resort to 
diluted oxytocin, which was directly injected in 
pseudocapsule of intramural and subserosal 
myomas of 16 women undergoing cesarean 
myomectomy and compared the results with a 
same sample cesarean delivery control group. 
Although the interesting idea proposed neither 
mean blood loss, hemoglobin levels and trans-
fusion rate nor other surgical outcomes, as 
length of hospitalization and febrile illness were 
significantly different between the two groups 
(Brown et al. 1999).  Later Ehigiegba et al on a 
sample of 25 pregnant women underwent ce-
sarean myomectomy, experienced the use of in-
travenous oxytocin administrated in high dose 
immediately after delivery of the baby. They re-
ported only five patients required blood trans-
fusion and no one needed hysterectomy, there-
fore the authors concluded that high dose of 
oxytocin infusion intra and post-operatively 
could be a safe and wise choice Ehigiegba (Ehi-
giegba, Ande, and Ojobo 2001). On the contra-
ry Dedes et al claimed that the use of uteroton-
ics does not significantly modify the outcome 
following cesarean myomectomy rather than 
cesarean delivery alone, shifting the focus on 
other variables possibly related to peri-operative 
complications, as myoma and patients’ charac-
teristics (Dedes et al. 2017). In the more recent 
prospective study conducted by Rai and Mishra 
a possible solution used to prevent or minimize 
bleeding at myoma bed immediately after my-
oma removal during cesarean delivery is the lo-
cal infiltration of dilute adrenaline, managing to 
achieving good results with a 20% of incidence 
of hemorrhage in the study group and no hys-
terectomy required at all. The data reported has 
been affected by the three cases of atonic peri-
partum hemorrhage in cesarean myomectomy 
group, treated with stepwise devascularization 
until adequate bleeding control (Rai and Mishra 
2017). Considering this eventuality it is advisa-
ble to perform myomectomy always after baby 
extraction and afterbirth, even when the myo-
ma is located anterior at the lower uterine seg-
ment, even if this let surgeon to opt for an unu-
sual uterine incision as the longitudinal and/or 
corporal one, because in case of massive hem-
orrhage is fundamental to have clearly visible 
anatomical landmarks for proper and safe 
devascularization. About that several surgical 
techniques have been described recently for 
blood loss sparing during cesarean myomecto-
my. When a case on the basis of patient’s and 
myoma’s characteristics could be more exposed 
to massive blood loss is possible temporary 
block the uterine arteries bilaterally both using 
tourniquet and ligating or clamping them with a 
soft-ended instrument.  Sapmaz et al published 
a randomized prospective study on a sample of 
70 women in order to compare the effective-
ness of the two methods mentioned above dur-
ing cesarean section. They showed no statisti-
cally significant differences in term of peri-
operative blood loss between the use of tourni-
quet and the bilateral ascending uterine artery 
ligation, however it emerged that only this latter 
strategy ensured a good blood loss control even 
in the postoperative period, so that in the view 
of the authors it should be prefer (Sapmaz, Ce-
lik, and Altungul 2003). Instead Kwawukume 
did not evidence statistically proved benefit in 
the use of tourniquet tied both around the uter-
ine arteries and ovarian vessels during cesarean 
myomectomy in comparison with cesarean 
alone in terms of blood sparing (Kwawukume 
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2002). Another possible choice is the electro-
cautery of myoma at the time of cesarean my-
omectomy as successfully experimented by Co-
bellis et al in 2002 on two cases of multiple fi-
broids of little or middle size (Cobellis et al. 
2002). Moreover Incebyik et al. proposed the 
use of electro surgery associated to tourniquet 
and oxytocin infusion as bleeding prevent strat-
egy for cesarean myomectomy. According to 
this approach first tourniquet is temporary ap-
plied at the cervico-istmic level, passing 
through the broad ligament, so electrocautery is 
employed for myoma removal and at the end of 
the uterine suture tourniquet is removed; post-
operatively intravenous oxytocin is adminis-
tered up to reach adequate uterine contraction. 
The results were encouraging and only two out 
of 16 patients required blood transfusion (In-
cebiyik et al. 2014). 
 
8. Cesarean myomectomy outcomes 
 
Assessing the intra and post-operative compli-
cation of cesarean myomectomy led many au-
thors to explore the possible variables of each 
cases, which could affect the outcome of the 
procedure in order to have a clearly and wise 
evaluation of the case preoperatively, eventually 
guiding the choice to do or not myoma removal 
at the time of cesarean delivery. In these terms 
a really interesting study is the retrospective one 
conducted by Dedes et al in 2017, in which 
emerges that the significant increase of blood 
loss, meant as ≥500mL (p=0.02),  rather that 
associated with the cesarean myomectomy pro-
cedure itself is related to large myoma size of 
≥5cm, which, according to the results reported, 
is linked to this complication independent of a 
concomitant myomectomy or not (Dedes et al. 
2017). This overturns at the same time both the 
idea to avoid cesarean section anyway and the 
idea of the absolute safety to not treat myoma 
during cesarean section. Maybe in this case re-
moving myoma with a correct and wise tech-
nique could be the safer choice in spite of the 
risk? And if Zhao et al remarks the augmenta-
tion of risk of bleeding with myoma larger than 
5cm maximum of diameter (Zhao et al. 2019), 
on the other hand Ehigiegba et al concluded 
that, employing the right technical precautions, 
even in case of big myoma cesarean myomec-
tomy could be a safe option for the patient and 
for the surgeon (Ehigiegba, Ande, and Ojobo 
2001). The question of the impact of the size of 
myoma on safety of cesarean myomectomy has 
been also well investigated by Kwon et al in 
their retrospective study of 2014, in which en-
rolled 65 patients underwent myomectomy ver-
sus 96 controls and, using the threshold of 5cm 
to differentiate the myoma labelled as large or 
not, did not find any statistically significant dif-
ferences in consideration of the mean hemo-
globin change, operative time and length of 
hospitalization (Kwon et al. 2014). Another an-
cient doubt is about the possible affection of 
the position of myoma on a greater incidence 
of bleeding, as a matter of fact in the past, while 
pedunculated or subserosal myoma removal 
was considered relatively safe during cesarean 
delivery, not the same point of view there was 
for the intramural lesions because of the feared 
relationship hypotized between the larger my-
ometrium wound following removal and the in-
cidence of atony and so massive blood loss. Ac-
tually, all the observational study up to nowa-
days do not report a statistical correlation be-
tween this complication and myoma location 
(Pergialiotis et al. 2017). On the other hand, is 
not well explored the real risk linked to a multi-
ple myomectomy during cesarean section, 
mostly because almost the totality of the obser-
vational study excluded patients affected by 
more than one myoma, especially large and 
with different position, in order to prevent 
worst outcome. Dedes et al tried to dissipate 
this doubt and effectively found a greater inci-
dence of massive blood loss in multiple cesare-
an myomectomies rather than the removal of 
single pedunculated or subserosal and intramu-
ral leiomyomas during cesarean section (OR re-
spectively of 4.7 and 1.1.-1.4, 95% CI 0.8-26.3) 
(Dedes et al. 2017). The interpretation of these 
results could debatable in relation to the too 
much low threshold employed to define hemor-
rhage, 500mL, but to date are still one of the 
studies of reference on this question. None of 
the observational studies published evidence a 
significant relationship between the augmenta-
tion of intra and postoperative surgical and clin-
ical risk and characteristics of the patient, with 
the exception of Dedes et al, who registered a 
significant postoperative drop in hemoglobin in 
women ≥40 years of age (OR 2.4 CI 95% 1.0–
5.4, p=0.04) (Dedes et al. 2017). However, this 
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remains a controversial data which is not sup-
ported by other studies and so it could be con-
sidered not useful for practical implications. 
Since the first attempt of cesarean myomecto-
my a technical constant, as reported above, is 
the need to postpone the myoma removing af-
ter baby extraction and  placental expulsion not 
only for the anatomical reason already exposed, 
but also to ensure good neonatal outcomes, 
which in every study published are not affected 
in any way by the procedure, and at the same 
time to eventually manage first placenta related 
complications without getting worse maternal 
outcomes. 
 
9. Surgical techniques to remove fibroids during cesarean 
section 
 
On the other hand, contrary to Bonney’s time, 
when gravid uterus used to be incised longitu-
dinally (Jauniaux and Khan 2014), the recent 
attempts of cesarean myomectomy have been 
done in line with the more current and safer in-
dications for cesarean section, according to 
which it should be preferable, when it is possi-
ble, a transverse incision of the inferior segment 
of the uterus to access to the uterine cavity for 
baby extraction. This consideration is funda-
mental for a preliminary evaluation, because the 
aim of the surgeon should be to try to limit the 
incision sites for myoma or myomas removing, 
using in all case is possible the incision just 
done. So that the myoma location predict the 
eventual necessity of further uterine incision 
over the extraction one and so, because of the 
number of the scars it could be needed, it could 
be a predictor of major risk of blood loss. Con-
sidering that anterior isthmic myomas could be 
the most eligible to cesarean myomectomy. In-
stead when additional incisions are needed dif-
ferent approach can be considered. In particular 
many of the different studies mentioned above 
do not the type of procedure employed to re-
moval myoma and, when the incision of the 
uterine segment is not used, the conventional 
choice is a serosal myomectomy, which is per-
formed through an incision over the site of 
myoma by the external face of the uterine wall, 
from which myoma is enucleated and then the 
dead space is closed. On the contrary recently a 
new and controversial technique has been pro-
posed in a retrospective single institution study 
by Hatırnaz et al, the so called “endometrial 
myomectomy”, which would be a less invasive 
and safer rather than the conventional fashion. 
As a matter of fact it is characterized by a small 
trans-endometrial incision at the site of myoma, 
performed after a quick and accurate visual and 
palpatory evaluation of location of the lesion, 
through which myoma is removed within the 
pseudocapsule; uterine breach is sutured only 
when the defect site is larger than 3cm with ab-
sorbable suture (Hatırnaz et al. 2020). The two 
main benefits of this procedure are: the absence 
of further scar on uterine surface and so the re-
duced risk of adhesion onset; the very small in-
cision on the inner uterine surface which 
should be associated with a statistical significant 
lower intraoperative bleeding rather than sero-
sal myomectomy (209mL versus 375mL, 
p=0.001) without at the same time the concrete 
remotely risk of intracavity adhesions or Ash-
ermann syndrome (Hatırnaz et al. 2020). In 
spite of these considerations the endometrial 
approach has been criticized for several reason, 
like the possible affection of endometrial role in 
reproductive process (52) or the consequently 
higher risk of abnormal placentation (Sparić et 
al. 2017), but no evidences are available to date. 
Much more distinctive is the disagreement of 
Tinelli about the fibroid removal during cesare-
an myomectomy (Sparić et al. 2017), remarking 
the fundamental role of a “myoma pseudocap-
sule sparing” approach, described first by him-
self in 2014 (Tinelli et al. 2014). In fact, accord-
ing to the biological mechanism that guide a 
correct wound healing in order to have better 
outcome especially in a so controversial proce-
dure like cesarean myomectomy should be fun-
damental opting for the safest and optimal sur-
gical strategy. Actually, scientific community 
has discovered the fundamental role of pseudo-
capsule in the management of fibroids, demon-
strating that a preservation of the latter repre-
sents a way to preserve all the structure funda-
mental for a correct healing, like vessels, neuro-
transmitters, and neuropeptides, involved in in-
ter-intracellular signalling. In order to correctly 
perform an intracapsular myoma removing dur-
ing cesarean section according to Tinelli et al. it 
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is essential to do a sharp and exact dissection of 
the pseudocapsule and then to do an accurate 
approximation of the edges of the myometrium 
with a complete closure of all dead space 
(Tinelli et al. 2014). Applying this approach in-
teresting really good outcomes has been regis-
tered in literature, in fact the 2014 prospective 
study conducted by Tinelli reported a mean 
hemoglobin decline lower in intracapsular ce-
sarean myomectomy group rather than in ce-
sarean delivery without myomectomy group 
(respectively 1.5 versus 1.6) (Tinelli et al. 2014), 
a result which is totally against the trend of the 
remaining observational study, with the only 
exception of Kwon et al (Kwon et al. 2014).  
Huang S.Y. et al fused the novel trans endome-
trial cesarean myomectomy technique proposed 
by Hatırnaz et al with the pseudocapsule spar-
ing approach of Tinelli et al, demonstrating that 
it could be a safe treatment option without 
long-term adverse surgical outcomes and with 
better obstetric outcomes of subsequent preg-
nancy (Huang et al. 2018). 
Another variable of cesarean myomectomy 
technique affecting clinical and surgical out-
comes is the way chosen to obliterate the my-
ometrium breach after myoma removal. As a 
matter of fact, mostly when an additional inci-
sion is needed to do or complete myomectomy, 
all the dead space have to be completely closed, 
otherwise that site can become full of blood 
and seat of hematoma with all the complica-
tions related. To date, we are not studies which 
investigated the best technique, instead each au-
thor reported several ways to closure according 
to the surgeon’s experience. As can be seen 
from the various studies in the literature, fi-
broid bed can be sutured, beginning from the 
bottom, with one or more layers of interrupted 
Vicryl suture, generally choosing the size of 
needle on the basis of the myoma bed, up to a 
complete myometrial wall closure and with the 
aim to achieve haemostasis. For the superficial 
layer the surgeon can opt for continuous suture, 
introflexing or not, or simply for X stiches 
(36,39,43,44).(Sparić et al. 2018; Hatırnaz et al. 
2020; Tinelli et al. 2014; Rai and Mishra 2017). 
 
10. Conclusions 
 
For a long time, it has been common and 
shared thinking that myoma should not be sur-
gically treated in pregnant women at the time of 
birth through cesarean section in order to avoid 
complications for the patient. Nowadays the in-
creasingly evidences reported in literature are 
gradually subvert the obstetrician point of view, 
leading to a concrete revaluation of this proce-
dure.   
Currently, the lack of randomized control trials 
make difficult to absolutely state the safety of 
the procedure and at the same time to defini-
tively standardize the indications, but the sever-
al conclusions of all the observational studies 
available up to now surely give us elements to 
guide the choice to do cesarean myomectomy 
in specific set of women. Moreover, besides the 
clinical feasibility of the procedure itself, au-
thors’ experience and judgment agree with the 
evidences about the importance of the experi-
ence of the operator both to make safer the 
surgical procedure and to have intra-operative 
and after-surgery outcomes. However, the type 
technique should be preferred and then in-
formative counselling and/or consensus com-
plete of higher quality data than those currently 
available are topics that need standardization to 
make cesarean myomectomy safer for the pa-
tients and for the operator at the same time. 
Therefore, we can conclude that a knowledge 
of all the aspects of this apparently controver-
sial surgical procedure plus a consolidated sur-
gical experience can give the instrument to of-
fer an additional safe option of treatment, 
which to date cannot longer be avoided a priori, 
aiming to a tailored treatment for each patient.  
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